In the promptly evolving discipline of cancer therapeutics, knowing the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is essential for acquiring successful therapies. One of the more promising strategies is using in vitro bystander influence assays, which play a pivotal role in enhancing therapeutic efficacy. These assays, supplied by bus